Literature DB >> 1422741

Endotoxin, septic shock and acute lung injury: neutrophils, macrophages and inflammatory mediators.

C R Welbourn1, Y Young.   

Abstract

The treatment of septic shock remains a major problem in surgical practice. Current research on the pathogenesis of the sepsis syndrome focuses on the effects of the lipopolysaccharide constituents of bacterial endotoxin. Evidence suggests that endotoxin induces a whole-body inflammatory response that in turn mediates organ damage, eventually leading to multiorgan failure. The first organ in which failure is usually apparent is the lung, with the appearance of non-cardiogenic pulmonary oedema as part of the adult respiratory distress syndrome. Inflammatory cells involved in lung injury include neutrophils and macrophages, which release mediators such as elastase, oxygen radicals and cytokines. This review summarizes current experimental work on how endotoxin leads to lung injury, based on its effects in animals and patients. Present knowledge suggests that future treatment of septic shock might involve inhibiting the body's inflammatory response to endotoxin. Possible ways of doing this are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422741     DOI: 10.1002/bjs.1800791006

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  41 in total

1.  E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide.

Authors:  T Kawata; J R Bristol; D P Rossignol; J R Rose; S Kobayashi; H Yokohama; A Ishibashi; W J Christ; K Katayama; I Yamatsu; Y Kishi
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins.

Authors:  J R Rose; M A Mullarkey; W J Christ; L D Hawkins; M Lynn; Y Kishi; K M Wasan; K Peteherych; D P Rossignol
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

3.  Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs.

Authors:  Graciela Andonegui; Claudine S Bonder; Francis Green; Sarah C Mullaly; Lori Zbytnuik; Eko Raharjo; Paul Kubes
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 4.  Intravascular immunity: the host-pathogen encounter in blood vessels.

Authors:  Michael J Hickey; Paul Kubes
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

Review 5.  Platelets and innate immunity.

Authors:  John W Semple; John Freedman
Journal:  Cell Mol Life Sci       Date:  2009-12-18       Impact factor: 9.261

Review 6.  Is sepsis a mediator-inhibitor mismatch?

Authors:  M Lamy; G Deby-Dupont
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

Review 7.  Platelets and the immune continuum.

Authors:  John W Semple; Joseph E Italiano; John Freedman
Journal:  Nat Rev Immunol       Date:  2011-04       Impact factor: 53.106

8.  Systemic adverse reactions in young Simmental calves following administration of a combination vaccine.

Authors:  J A Ellis; C Yong
Journal:  Can Vet J       Date:  1997-01       Impact factor: 1.008

9.  Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gram-negative bacterial infection.

Authors:  Graciela Andonegui; Hong Zhou; Daniel Bullard; Margaret M Kelly; Sarah C Mullaly; Braedon McDonald; Elizabeth M Long; Stephen M Robbins; Paul Kubes
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

10.  Distinct tumor necrosis factor-alpha responses in alveolar and peritoneal macrophages are associated with local levels of endotoxin.

Authors:  L F Wang; K Tomita; T Sasaki
Journal:  Inflammation       Date:  1998-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.